Atea Pharmaceuticals, Inc. (AVIR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.94 | +3.0% |
| 2024 | $-2.00 | -22.7% |
| 2023 | $-1.63 | -17.3% |
| 2022 | $-1.39 | -201.5% |
| 2021 | $1.37 | +368.6% |
| 2020 | $-0.51 | +63.3% |
| 2019 | $-1.39 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.94 | +3.0% |
| 2024 | $-2.00 | -22.7% |
| 2023 | $-1.63 | -17.3% |
| 2022 | $-1.39 | -201.5% |
| 2021 | $1.37 | +368.6% |
| 2020 | $-0.51 | +63.3% |
| 2019 | $-1.39 | — |